nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—CHRM2—alcohol dependence	0.655	1	CbGaD
Procainamide—SCN3A—spinal nerve—alcohol dependence	0.0126	0.102	CbGeAlD
Procainamide—SCN8A—cerebellar cortex—alcohol dependence	0.0108	0.0881	CbGeAlD
Procainamide—Gastrointestinal tract irritation—Naltrexone—alcohol dependence	0.006	0.0519	CcSEcCtD
Procainamide—SCN11A—nerve—alcohol dependence	0.00525	0.0426	CbGeAlD
Procainamide—SCN8A—nerve—alcohol dependence	0.00398	0.0323	CbGeAlD
Procainamide—Hepatic failure—Disulfiram—alcohol dependence	0.00372	0.0321	CcSEcCtD
Procainamide—Psychotic disorder—Disulfiram—alcohol dependence	0.00326	0.0282	CcSEcCtD
Procainamide—Abdominal discomfort—Disulfiram—alcohol dependence	0.00277	0.0239	CcSEcCtD
Procainamide—SCN10A—nerve—alcohol dependence	0.00266	0.0216	CbGeAlD
Procainamide—Hepatic enzyme increased—Naltrexone—alcohol dependence	0.00227	0.0196	CcSEcCtD
Procainamide—Moclobemide—MAOB—alcohol dependence	0.00219	0.337	CrCbGaD
Procainamide—Rash maculo-papular—Acamprosate—alcohol dependence	0.00206	0.0178	CcSEcCtD
Procainamide—SCN8A—brainstem—alcohol dependence	0.00171	0.0139	CbGeAlD
Procainamide—Arthritis—Acamprosate—alcohol dependence	0.00169	0.0146	CcSEcCtD
Procainamide—Cardiac failure—Acamprosate—alcohol dependence	0.00169	0.0146	CcSEcCtD
Procainamide—SCN8A—forebrain—alcohol dependence	0.00165	0.0134	CbGeAlD
Procainamide—Atrial fibrillation—Naltrexone—alcohol dependence	0.00164	0.0142	CcSEcCtD
Procainamide—Psychotic disorder—Acamprosate—alcohol dependence	0.00161	0.0139	CcSEcCtD
Procainamide—Arthritis—Naltrexone—alcohol dependence	0.0016	0.0138	CcSEcCtD
Procainamide—Lethargy—Naltrexone—alcohol dependence	0.00159	0.0137	CcSEcCtD
Procainamide—SCN7A—cardiovascular system—alcohol dependence	0.00156	0.0127	CbGeAlD
Procainamide—Moclobemide—MAOA—alcohol dependence	0.00153	0.236	CrCbGaD
Procainamide—SCN11A—digestive system—alcohol dependence	0.00153	0.0124	CbGeAlD
Procainamide—Psychotic disorder—Naltrexone—alcohol dependence	0.00152	0.0131	CcSEcCtD
Procainamide—Oliguria—Citalopram—alcohol dependence	0.00147	0.0127	CcSEcCtD
Procainamide—Hepatic enzyme increased—Citalopram—alcohol dependence	0.00144	0.0124	CcSEcCtD
Procainamide—Abdominal pain upper—Naltrexone—alcohol dependence	0.00142	0.0123	CcSEcCtD
Procainamide—DNMT1—forebrain—alcohol dependence	0.00142	0.0115	CbGeAlD
Procainamide—Eosinophilia—Acamprosate—alcohol dependence	0.00141	0.0122	CcSEcCtD
Procainamide—Ventricular tachycardia—Citalopram—alcohol dependence	0.00136	0.0117	CcSEcCtD
Procainamide—DNMT1—adrenal cortex—alcohol dependence	0.00132	0.0107	CbGeAlD
Procainamide—SCN1A—brainstem—alcohol dependence	0.00129	0.0105	CbGeAlD
Procainamide—Abdominal discomfort—Naltrexone—alcohol dependence	0.00129	0.0111	CcSEcCtD
Procainamide—Depression—Acamprosate—alcohol dependence	0.00126	0.0109	CcSEcCtD
Procainamide—SCN1A—forebrain—alcohol dependence	0.00124	0.0101	CbGeAlD
Procainamide—Rash maculo-papular—Citalopram—alcohol dependence	0.00123	0.0107	CcSEcCtD
Procainamide—Lightheadedness—Citalopram—alcohol dependence	0.00122	0.0105	CcSEcCtD
Procainamide—DNMT1—cardiovascular system—alcohol dependence	0.0012	0.00975	CbGeAlD
Procainamide—Depression—Naltrexone—alcohol dependence	0.0012	0.0103	CcSEcCtD
Procainamide—SCN2A—brainstem—alcohol dependence	0.00118	0.00962	CbGeAlD
Procainamide—SCN11A—nervous system—alcohol dependence	0.00118	0.00959	CbGeAlD
Procainamide—Asthenia—Disulfiram—alcohol dependence	0.00118	0.0102	CcSEcCtD
Procainamide—SCN2A—forebrain—alcohol dependence	0.00114	0.00929	CbGeAlD
Procainamide—SCN11A—central nervous system—alcohol dependence	0.00114	0.00923	CbGeAlD
Procainamide—Hallucination—Acamprosate—alcohol dependence	0.00113	0.00978	CcSEcCtD
Procainamide—SCN10A—forebrain—alcohol dependence	0.0011	0.00895	CbGeAlD
Procainamide—Hepatic failure—Citalopram—alcohol dependence	0.0011	0.00948	CcSEcCtD
Procainamide—Chloroprocaine—SLC6A3—alcohol dependence	0.0011	0.169	CrCbGaD
Procainamide—Haemolytic anaemia—Citalopram—alcohol dependence	0.00109	0.00944	CcSEcCtD
Procainamide—DNMT1—gonad—alcohol dependence	0.00109	0.00885	CbGeAlD
Procainamide—Dizziness—Disulfiram—alcohol dependence	0.00109	0.00937	CcSEcCtD
Procainamide—SCN7A—endocrine gland—alcohol dependence	0.00107	0.00871	CbGeAlD
Procainamide—Hallucination—Naltrexone—alcohol dependence	0.00107	0.00925	CcSEcCtD
Procainamide—Procaine—SLC6A3—alcohol dependence	0.00105	0.161	CrCbGaD
Procainamide—Atrial fibrillation—Citalopram—alcohol dependence	0.00104	0.00899	CcSEcCtD
Procainamide—SCN7A—testis—alcohol dependence	0.00102	0.00831	CbGeAlD
Procainamide—Chills—Acamprosate—alcohol dependence	0.00102	0.00882	CcSEcCtD
Procainamide—Arthritis—Citalopram—alcohol dependence	0.00101	0.00876	CcSEcCtD
Procainamide—Cardiac failure—Citalopram—alcohol dependence	0.00101	0.00873	CcSEcCtD
Procainamide—Lethargy—Citalopram—alcohol dependence	0.00101	0.00869	CcSEcCtD
Procainamide—SCN3A—forebrain—alcohol dependence	0.001	0.00816	CbGeAlD
Procainamide—Cardiac disorder—Naltrexone—alcohol dependence	0.000999	0.00863	CcSEcCtD
Procainamide—DNMT1—digestive system—alcohol dependence	0.000996	0.0081	CbGeAlD
Procainamide—Dysgeusia—Acamprosate—alcohol dependence	0.00097	0.00838	CcSEcCtD
Procainamide—SCN7A—liver—alcohol dependence	0.000966	0.00785	CbGeAlD
Procainamide—Chills—Naltrexone—alcohol dependence	0.000966	0.00834	CcSEcCtD
Procainamide—Psychotic disorder—Citalopram—alcohol dependence	0.000963	0.00832	CcSEcCtD
Procainamide—SCN9A—midbrain—alcohol dependence	0.000956	0.00777	CbGeAlD
Procainamide—SCN8A—endocrine gland—alcohol dependence	0.000955	0.00776	CbGeAlD
Procainamide—DNMT1—blood—alcohol dependence	0.000949	0.00771	CbGeAlD
Procainamide—Cardiac arrest—Citalopram—alcohol dependence	0.000938	0.0081	CcSEcCtD
Procainamide—DNMT1—midbrain—alcohol dependence	0.000937	0.00762	CbGeAlD
Procainamide—Ill-defined disorder—Acamprosate—alcohol dependence	0.000919	0.00794	CcSEcCtD
Procainamide—Dysgeusia—Naltrexone—alcohol dependence	0.000918	0.00793	CcSEcCtD
Procainamide—SCN8A—testis—alcohol dependence	0.000911	0.0074	CbGeAlD
Procainamide—Angioedema—Acamprosate—alcohol dependence	0.000905	0.00782	CcSEcCtD
Procainamide—SCN11A—brain—alcohol dependence	0.000902	0.00733	CbGeAlD
Procainamide—Abdominal pain upper—Citalopram—alcohol dependence	0.000901	0.00778	CcSEcCtD
Procainamide—SCN8A—nervous system—alcohol dependence	0.000894	0.00727	CbGeAlD
Procainamide—Malaise—Acamprosate—alcohol dependence	0.000893	0.00772	CcSEcCtD
Procainamide—Ill-defined disorder—Naltrexone—alcohol dependence	0.00087	0.00751	CcSEcCtD
Procainamide—SCN8A—central nervous system—alcohol dependence	0.000861	0.007	CbGeAlD
Procainamide—Convulsion—Acamprosate—alcohol dependence	0.000858	0.00741	CcSEcCtD
Procainamide—Angioedema—Naltrexone—alcohol dependence	0.000856	0.0074	CcSEcCtD
Procainamide—CHRM2—forebrain—alcohol dependence	0.000852	0.00693	CbGeAlD
Procainamide—SCN5A—cardiovascular system—alcohol dependence	0.000847	0.00688	CbGeAlD
Procainamide—Malaise—Naltrexone—alcohol dependence	0.000845	0.0073	CcSEcCtD
Procainamide—Eosinophilia—Citalopram—alcohol dependence	0.000844	0.00729	CcSEcCtD
Procainamide—Arthralgia—Acamprosate—alcohol dependence	0.000843	0.00728	CcSEcCtD
Procainamide—Myalgia—Acamprosate—alcohol dependence	0.000843	0.00728	CcSEcCtD
Procainamide—SCN8A—cerebellum—alcohol dependence	0.000841	0.00684	CbGeAlD
Procainamide—SLC22A1—forebrain—alcohol dependence	0.000837	0.00681	CbGeAlD
Procainamide—Discomfort—Acamprosate—alcohol dependence	0.000833	0.0072	CcSEcCtD
Procainamide—SLC22A2—digestive system—alcohol dependence	0.000832	0.00676	CbGeAlD
Procainamide—DNMT1—endocrine gland—alcohol dependence	0.000823	0.00669	CbGeAlD
Procainamide—SCN1A—midbrain—alcohol dependence	0.000822	0.00668	CbGeAlD
Procainamide—Abdominal discomfort—Citalopram—alcohol dependence	0.000817	0.00706	CcSEcCtD
Procainamide—Confusional state—Acamprosate—alcohol dependence	0.000815	0.00704	CcSEcCtD
Procainamide—Convulsion—Naltrexone—alcohol dependence	0.000812	0.00701	CcSEcCtD
Procainamide—SCN9A—testis—alcohol dependence	0.000801	0.00651	CbGeAlD
Procainamide—Arthralgia—Naltrexone—alcohol dependence	0.000798	0.00689	CcSEcCtD
Procainamide—Myalgia—Naltrexone—alcohol dependence	0.000798	0.00689	CcSEcCtD
Procainamide—Shock—Acamprosate—alcohol dependence	0.000795	0.00687	CcSEcCtD
Procainamide—Thrombocytopenia—Acamprosate—alcohol dependence	0.000792	0.00684	CcSEcCtD
Procainamide—Discomfort—Naltrexone—alcohol dependence	0.000788	0.00681	CcSEcCtD
Procainamide—DNMT1—testis—alcohol dependence	0.000785	0.00638	CbGeAlD
Procainamide—Confusional state—Naltrexone—alcohol dependence	0.000771	0.00666	CcSEcCtD
Procainamide—Anorexia—Acamprosate—alcohol dependence	0.000771	0.00666	CcSEcCtD
Procainamide—DNMT1—nervous system—alcohol dependence	0.000771	0.00626	CbGeAlD
Procainamide—SCN7A—brain—alcohol dependence	0.000767	0.00623	CbGeAlD
Procainamide—SCN2A—blood—alcohol dependence	0.000764	0.00621	CbGeAlD
Procainamide—ACHE—midbrain—alcohol dependence	0.000761	0.00619	CbGeAlD
Procainamide—Depression—Citalopram—alcohol dependence	0.000758	0.00655	CcSEcCtD
Procainamide—Hypotension—Acamprosate—alcohol dependence	0.000756	0.00653	CcSEcCtD
Procainamide—SCN2A—midbrain—alcohol dependence	0.000755	0.00613	CbGeAlD
Procainamide—Shock—Naltrexone—alcohol dependence	0.000753	0.0065	CcSEcCtD
Procainamide—DNMT1—liver—alcohol dependence	0.000742	0.00603	CbGeAlD
Procainamide—DNMT1—central nervous system—alcohol dependence	0.000742	0.00603	CbGeAlD
Procainamide—SCN10A—blood—alcohol dependence	0.000737	0.00599	CbGeAlD
Procainamide—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000737	0.00636	CcSEcCtD
Procainamide—Anorexia—Naltrexone—alcohol dependence	0.000729	0.0063	CcSEcCtD
Procainamide—DNMT1—cerebellum—alcohol dependence	0.000725	0.00589	CbGeAlD
Procainamide—CHRM2—cardiovascular system—alcohol dependence	0.000721	0.00586	CbGeAlD
Procainamide—SCN4A—testis—alcohol dependence	0.000714	0.0058	CbGeAlD
Procainamide—Agranulocytosis—Citalopram—alcohol dependence	0.000709	0.00613	CcSEcCtD
Procainamide—SCN5A—digestive system—alcohol dependence	0.000703	0.00571	CbGeAlD
Procainamide—Decreased appetite—Acamprosate—alcohol dependence	0.000703	0.00607	CcSEcCtD
Procainamide—SCN4A—nervous system—alcohol dependence	0.000701	0.0057	CbGeAlD
Procainamide—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000697	0.00602	CcSEcCtD
Procainamide—Bradycardia—Citalopram—alcohol dependence	0.000695	0.006	CcSEcCtD
Procainamide—SCN8A—brain—alcohol dependence	0.000683	0.00555	CbGeAlD
Procainamide—Hallucination—Citalopram—alcohol dependence	0.000679	0.00586	CcSEcCtD
Procainamide—SCN1A—nervous system—alcohol dependence	0.000676	0.00549	CbGeAlD
Procainamide—SCN4A—central nervous system—alcohol dependence	0.000675	0.00548	CbGeAlD
Procainamide—SCN3A—blood—alcohol dependence	0.000672	0.00546	CbGeAlD
Procainamide—SCN5A—blood—alcohol dependence	0.00067	0.00544	CbGeAlD
Procainamide—Feeling abnormal—Acamprosate—alcohol dependence	0.000666	0.00575	CcSEcCtD
Procainamide—Decreased appetite—Naltrexone—alcohol dependence	0.000665	0.00574	CcSEcCtD
Procainamide—SCN3A—midbrain—alcohol dependence	0.000663	0.00539	CbGeAlD
Procainamide—SCN2A—endocrine gland—alcohol dependence	0.000663	0.00539	CbGeAlD
Procainamide—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000661	0.00571	CcSEcCtD
Procainamide—SCN1A—central nervous system—alcohol dependence	0.000651	0.00529	CbGeAlD
Procainamide—Urticaria—Acamprosate—alcohol dependence	0.000642	0.00555	CcSEcCtD
Procainamide—Abdominal pain—Acamprosate—alcohol dependence	0.000639	0.00552	CcSEcCtD
Procainamide—Body temperature increased—Acamprosate—alcohol dependence	0.000639	0.00552	CcSEcCtD
Procainamide—SCN10A—endocrine gland—alcohol dependence	0.000639	0.00519	CbGeAlD
Procainamide—ACHE—testis—alcohol dependence	0.000638	0.00518	CbGeAlD
Procainamide—SCN1A—cerebellum—alcohol dependence	0.000636	0.00517	CbGeAlD
Procainamide—Metoclopramide—DRD2—alcohol dependence	0.000634	0.0976	CrCbGaD
Procainamide—Flushing—Citalopram—alcohol dependence	0.000633	0.00547	CcSEcCtD
Procainamide—Cardiac disorder—Citalopram—alcohol dependence	0.000633	0.00547	CcSEcCtD
Procainamide—Feeling abnormal—Naltrexone—alcohol dependence	0.00063	0.00544	CcSEcCtD
Procainamide—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000626	0.0054	CcSEcCtD
Procainamide—SCN2A—nervous system—alcohol dependence	0.00062	0.00504	CbGeAlD
Procainamide—SLC22A4—digestive system—alcohol dependence	0.000617	0.00502	CbGeAlD
Procainamide—SLC22A3—gonad—alcohol dependence	0.000614	0.00499	CbGeAlD
Procainamide—Chills—Citalopram—alcohol dependence	0.000612	0.00529	CcSEcCtD
Procainamide—Urticaria—Naltrexone—alcohol dependence	0.000608	0.00525	CcSEcCtD
Procainamide—Abdominal pain—Naltrexone—alcohol dependence	0.000605	0.00522	CcSEcCtD
Procainamide—Body temperature increased—Naltrexone—alcohol dependence	0.000605	0.00522	CcSEcCtD
Procainamide—SCN9A—brain—alcohol dependence	0.000601	0.00488	CbGeAlD
Procainamide—SCN10A—nervous system—alcohol dependence	0.000598	0.00486	CbGeAlD
Procainamide—SCN2A—central nervous system—alcohol dependence	0.000597	0.00485	CbGeAlD
Procainamide—Hypersensitivity—Acamprosate—alcohol dependence	0.000596	0.00515	CcSEcCtD
Procainamide—ACHE—cerebellum—alcohol dependence	0.000589	0.00479	CbGeAlD
Procainamide—DNMT1—brain—alcohol dependence	0.000589	0.00479	CbGeAlD
Procainamide—SLC22A4—blood—alcohol dependence	0.000588	0.00478	CbGeAlD
Procainamide—BCHE—brainstem—alcohol dependence	0.000587	0.00477	CbGeAlD
Procainamide—SCN2A—cerebellum—alcohol dependence	0.000584	0.00474	CbGeAlD
Procainamide—Dysgeusia—Citalopram—alcohol dependence	0.000582	0.00502	CcSEcCtD
Procainamide—Asthenia—Acamprosate—alcohol dependence	0.00058	0.00501	CcSEcCtD
Procainamide—SCN10A—central nervous system—alcohol dependence	0.000576	0.00468	CbGeAlD
Procainamide—Pruritus—Acamprosate—alcohol dependence	0.000572	0.00494	CcSEcCtD
Procainamide—BCHE—forebrain—alcohol dependence	0.000567	0.00461	CbGeAlD
Procainamide—Hypersensitivity—Naltrexone—alcohol dependence	0.000564	0.00487	CcSEcCtD
Procainamide—SLC22A1—blood—alcohol dependence	0.00056	0.00455	CbGeAlD
Procainamide—SCN3A—testis—alcohol dependence	0.000555	0.00451	CbGeAlD
Procainamide—Diarrhoea—Acamprosate—alcohol dependence	0.000553	0.00478	CcSEcCtD
Procainamide—Ill-defined disorder—Citalopram—alcohol dependence	0.000551	0.00476	CcSEcCtD
Procainamide—Asthenia—Naltrexone—alcohol dependence	0.000549	0.00474	CcSEcCtD
Procainamide—SCN3A—nervous system—alcohol dependence	0.000545	0.00443	CbGeAlD
Procainamide—SCN5A—nervous system—alcohol dependence	0.000544	0.00442	CbGeAlD
Procainamide—Angioedema—Citalopram—alcohol dependence	0.000543	0.00469	CcSEcCtD
Procainamide—Pruritus—Naltrexone—alcohol dependence	0.000541	0.00467	CcSEcCtD
Procainamide—SLC22A5—adrenal cortex—alcohol dependence	0.000539	0.00438	CbGeAlD
Procainamide—SCN4A—brain—alcohol dependence	0.000536	0.00435	CbGeAlD
Procainamide—Malaise—Citalopram—alcohol dependence	0.000536	0.00463	CcSEcCtD
Procainamide—Dizziness—Acamprosate—alcohol dependence	0.000535	0.00462	CcSEcCtD
Procainamide—SCN3A—central nervous system—alcohol dependence	0.000525	0.00427	CbGeAlD
Procainamide—Diarrhoea—Naltrexone—alcohol dependence	0.000523	0.00452	CcSEcCtD
Procainamide—SCN5A—central nervous system—alcohol dependence	0.000523	0.00425	CbGeAlD
Procainamide—SCN1A—brain—alcohol dependence	0.000517	0.0042	CbGeAlD
Procainamide—Convulsion—Citalopram—alcohol dependence	0.000515	0.00444	CcSEcCtD
Procainamide—Vomiting—Acamprosate—alcohol dependence	0.000514	0.00444	CcSEcCtD
Procainamide—SCN3A—cerebellum—alcohol dependence	0.000513	0.00417	CbGeAlD
Procainamide—Dizziness—Naltrexone—alcohol dependence	0.000506	0.00437	CcSEcCtD
Procainamide—Myalgia—Citalopram—alcohol dependence	0.000506	0.00437	CcSEcCtD
Procainamide—Arthralgia—Citalopram—alcohol dependence	0.000506	0.00437	CcSEcCtD
Procainamide—Discomfort—Citalopram—alcohol dependence	0.0005	0.00431	CcSEcCtD
Procainamide—CHRM2—endocrine gland—alcohol dependence	0.000494	0.00402	CbGeAlD
Procainamide—Confusional state—Citalopram—alcohol dependence	0.000489	0.00422	CcSEcCtD
Procainamide—Vomiting—Naltrexone—alcohol dependence	0.000486	0.0042	CcSEcCtD
Procainamide—SLC22A1—endocrine gland—alcohol dependence	0.000486	0.00395	CbGeAlD
Procainamide—Nausea—Acamprosate—alcohol dependence	0.00048	0.00415	CcSEcCtD
Procainamide—BCHE—cardiovascular system—alcohol dependence	0.000479	0.00389	CbGeAlD
Procainamide—ACHE—brain—alcohol dependence	0.000478	0.00389	CbGeAlD
Procainamide—Shock—Citalopram—alcohol dependence	0.000477	0.00412	CcSEcCtD
Procainamide—Thrombocytopenia—Citalopram—alcohol dependence	0.000475	0.0041	CcSEcCtD
Procainamide—SCN2A—brain—alcohol dependence	0.000474	0.00385	CbGeAlD
Procainamide—SLC22A3—endocrine gland—alcohol dependence	0.000464	0.00377	CbGeAlD
Procainamide—CHRM2—nervous system—alcohol dependence	0.000463	0.00376	CbGeAlD
Procainamide—Anorexia—Citalopram—alcohol dependence	0.000462	0.00399	CcSEcCtD
Procainamide—SCN10A—brain—alcohol dependence	0.000457	0.00372	CbGeAlD
Procainamide—SLC22A1—nervous system—alcohol dependence	0.000455	0.00369	CbGeAlD
Procainamide—Nausea—Naltrexone—alcohol dependence	0.000454	0.00392	CcSEcCtD
Procainamide—Hypotension—Citalopram—alcohol dependence	0.000453	0.00391	CcSEcCtD
Procainamide—SLC22A4—cerebellum—alcohol dependence	0.000449	0.00365	CbGeAlD
Procainamide—CHRM2—central nervous system—alcohol dependence	0.000446	0.00362	CbGeAlD
Procainamide—SLC22A3—testis—alcohol dependence	0.000443	0.0036	CbGeAlD
Procainamide—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000442	0.00381	CcSEcCtD
Procainamide—SLC22A1—liver—alcohol dependence	0.000438	0.00356	CbGeAlD
Procainamide—SLC22A1—central nervous system—alcohol dependence	0.000438	0.00356	CbGeAlD
Procainamide—SLC22A3—nervous system—alcohol dependence	0.000434	0.00353	CbGeAlD
Procainamide—Decreased appetite—Citalopram—alcohol dependence	0.000421	0.00364	CcSEcCtD
Procainamide—SLC22A3—liver—alcohol dependence	0.000418	0.0034	CbGeAlD
Procainamide—SLC22A3—central nervous system—alcohol dependence	0.000418	0.0034	CbGeAlD
Procainamide—SCN3A—brain—alcohol dependence	0.000417	0.00339	CbGeAlD
Procainamide—SCN5A—brain—alcohol dependence	0.000416	0.00338	CbGeAlD
Procainamide—SLC22A5—digestive system—alcohol dependence	0.000408	0.00332	CbGeAlD
Procainamide—Feeling abnormal—Citalopram—alcohol dependence	0.000399	0.00345	CcSEcCtD
Procainamide—BCHE—digestive system—alcohol dependence	0.000398	0.00323	CbGeAlD
Procainamide—Gastrointestinal pain—Citalopram—alcohol dependence	0.000396	0.00342	CcSEcCtD
Procainamide—SLC22A5—blood—alcohol dependence	0.000389	0.00316	CbGeAlD
Procainamide—CYP2D6—brainstem—alcohol dependence	0.000389	0.00316	CbGeAlD
Procainamide—Urticaria—Citalopram—alcohol dependence	0.000385	0.00333	CcSEcCtD
Procainamide—SLC22A5—midbrain—alcohol dependence	0.000384	0.00312	CbGeAlD
Procainamide—Abdominal pain—Citalopram—alcohol dependence	0.000383	0.00331	CcSEcCtD
Procainamide—Body temperature increased—Citalopram—alcohol dependence	0.000383	0.00331	CcSEcCtD
Procainamide—BCHE—blood—alcohol dependence	0.000379	0.00308	CbGeAlD
Procainamide—CYP2D6—forebrain—alcohol dependence	0.000375	0.00305	CbGeAlD
Procainamide—BCHE—midbrain—alcohol dependence	0.000374	0.00304	CbGeAlD
Procainamide—SLC22A4—brain—alcohol dependence	0.000365	0.00297	CbGeAlD
Procainamide—Hypersensitivity—Citalopram—alcohol dependence	0.000357	0.00308	CcSEcCtD
Procainamide—CHRM2—brain—alcohol dependence	0.000354	0.00287	CbGeAlD
Procainamide—Asthenia—Citalopram—alcohol dependence	0.000348	0.003	CcSEcCtD
Procainamide—SLC22A1—brain—alcohol dependence	0.000347	0.00282	CbGeAlD
Procainamide—Pruritus—Citalopram—alcohol dependence	0.000343	0.00296	CcSEcCtD
Procainamide—SLC22A3—brain—alcohol dependence	0.000332	0.0027	CbGeAlD
Procainamide—Diarrhoea—Citalopram—alcohol dependence	0.000332	0.00286	CcSEcCtD
Procainamide—BCHE—endocrine gland—alcohol dependence	0.000329	0.00267	CbGeAlD
Procainamide—SLC22A5—testis—alcohol dependence	0.000322	0.00262	CbGeAlD
Procainamide—Dizziness—Citalopram—alcohol dependence	0.000321	0.00277	CcSEcCtD
Procainamide—BCHE—testis—alcohol dependence	0.000313	0.00255	CbGeAlD
Procainamide—Vomiting—Citalopram—alcohol dependence	0.000308	0.00266	CcSEcCtD
Procainamide—BCHE—nervous system—alcohol dependence	0.000308	0.0025	CbGeAlD
Procainamide—SLC22A5—liver—alcohol dependence	0.000304	0.00247	CbGeAlD
Procainamide—SLC22A5—cerebellum—alcohol dependence	0.000297	0.00242	CbGeAlD
Procainamide—BCHE—liver—alcohol dependence	0.000296	0.00241	CbGeAlD
Procainamide—BCHE—central nervous system—alcohol dependence	0.000296	0.00241	CbGeAlD
Procainamide—BCHE—cerebellum—alcohol dependence	0.00029	0.00235	CbGeAlD
Procainamide—Nausea—Citalopram—alcohol dependence	0.000288	0.00249	CcSEcCtD
Procainamide—CYP2D6—digestive system—alcohol dependence	0.000264	0.00214	CbGeAlD
Procainamide—CYP2D6—blood—alcohol dependence	0.000251	0.00204	CbGeAlD
Procainamide—SLC22A5—brain—alcohol dependence	0.000241	0.00196	CbGeAlD
Procainamide—BCHE—brain—alcohol dependence	0.000235	0.00191	CbGeAlD
Procainamide—CYP2D6—endocrine gland—alcohol dependence	0.000218	0.00177	CbGeAlD
Procainamide—CYP2D6—testis—alcohol dependence	0.000208	0.00169	CbGeAlD
Procainamide—CYP2D6—nervous system—alcohol dependence	0.000204	0.00166	CbGeAlD
Procainamide—CYP2D6—liver—alcohol dependence	0.000196	0.0016	CbGeAlD
Procainamide—CYP2D6—central nervous system—alcohol dependence	0.000196	0.00159	CbGeAlD
Procainamide—CYP2D6—cerebellum—alcohol dependence	0.000192	0.00156	CbGeAlD
Procainamide—CYP2D6—brain—alcohol dependence	0.000156	0.00127	CbGeAlD
Procainamide—CHRM2—G alpha (i) signalling events—OPRM1—alcohol dependence	0.000127	0.00127	CbGpPWpGaD
Procainamide—SLC22A2—Transmission across Chemical Synapses—GRIN2B—alcohol dependence	0.000126	0.00127	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—PDYN—alcohol dependence	0.000125	0.00126	CbGpPWpGaD
Procainamide—SLC22A2—Transmission across Chemical Synapses—SLC6A3—alcohol dependence	0.000124	0.00125	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—ALDH2—alcohol dependence	0.000122	0.00123	CbGpPWpGaD
Procainamide—ACHE—Neuronal System—GRIN2B—alcohol dependence	0.000121	0.00122	CbGpPWpGaD
Procainamide—ACHE—Neuronal System—SLC6A3—alcohol dependence	0.000119	0.0012	CbGpPWpGaD
Procainamide—SLC22A1—Transmission across Chemical Synapses—GRIN2B—alcohol dependence	0.000117	0.00118	CbGpPWpGaD
Procainamide—BCHE—Transmission across Chemical Synapses—MAOA—alcohol dependence	0.000117	0.00118	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—OPRM1—alcohol dependence	0.000117	0.00118	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—NPY—alcohol dependence	0.000116	0.00117	CbGpPWpGaD
Procainamide—SLC22A1—Transmission across Chemical Synapses—SLC6A3—alcohol dependence	0.000116	0.00116	CbGpPWpGaD
Procainamide—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000115	0.00115	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—ALDH2—alcohol dependence	0.000114	0.00115	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—HTR1B—alcohol dependence	0.000112	0.00113	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ADH1A—alcohol dependence	0.00011	0.0011	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—MAOA—alcohol dependence	0.000109	0.0011	CbGpPWpGaD
Procainamide—CYP2D6—Biological oxidations—MAOB—alcohol dependence	0.000109	0.0011	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.000108	0.00109	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—GRIN2B—alcohol dependence	0.000108	0.00109	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—AVP—alcohol dependence	0.000107	0.00108	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—SLC6A3—alcohol dependence	0.000107	0.00107	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000106	0.00107	CbGpPWpGaD
Procainamide—SLC22A2—Transmission across Chemical Synapses—MAOA—alcohol dependence	0.000105	0.00106	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ADH6—alcohol dependence	0.000104	0.00105	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1B—alcohol dependence	0.000104	0.00105	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—GRIN2B—alcohol dependence	0.000101	0.00102	CbGpPWpGaD
Procainamide—ACHE—Neuronal System—MAOA—alcohol dependence	0.000101	0.00101	CbGpPWpGaD
Procainamide—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—alcohol dependence	0.000101	0.00101	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—OPRM1—alcohol dependence	0.000101	0.00101	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—OPRD1—alcohol dependence	9.96e-05	0.001	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—GABRB1—alcohol dependence	9.91e-05	0.000997	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—DRD4—alcohol dependence	9.82e-05	0.000988	CbGpPWpGaD
Procainamide—SLC22A1—Transmission across Chemical Synapses—MAOA—alcohol dependence	9.77e-05	0.000984	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—GRIN2B—alcohol dependence	9.66e-05	0.000972	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—PDYN—alcohol dependence	9.55e-05	0.000961	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—SLC6A3—alcohol dependence	9.52e-05	0.000958	CbGpPWpGaD
Procainamide—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—alcohol dependence	9.39e-05	0.000944	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—CNR1—alcohol dependence	9.38e-05	0.000943	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ADH4—alcohol dependence	9.34e-05	0.00094	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ADH6—alcohol dependence	9.31e-05	0.000936	CbGpPWpGaD
Procainamide—CYP2D6—Biological oxidations—ALDH2—alcohol dependence	9.26e-05	0.000932	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPY—alcohol dependence	9.26e-05	0.000932	CbGpPWpGaD
Procainamide—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	9.21e-05	0.000927	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—DRD2—alcohol dependence	9.15e-05	0.00092	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—EP300—alcohol dependence	9.13e-05	0.000919	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—alcohol dependence	9.11e-05	0.000917	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—GABRA2—alcohol dependence	9.04e-05	0.00091	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—GRIN2B—alcohol dependence	9e-05	0.000906	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—MAOA—alcohol dependence	9e-05	0.000905	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—AVP—alcohol dependence	8.95e-05	0.0009	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—alcohol dependence	8.93e-05	0.000899	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—HTR2A—alcohol dependence	8.89e-05	0.000895	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CRHR1—alcohol dependence	8.87e-05	0.000893	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—SLC6A3—alcohol dependence	8.87e-05	0.000893	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—EP300—alcohol dependence	8.84e-05	0.00089	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—CNR1—alcohol dependence	8.7e-05	0.000876	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ADH1A—alcohol dependence	8.64e-05	0.00087	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—alcohol dependence	8.49e-05	0.000854	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR7—alcohol dependence	8.49e-05	0.000854	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	8.43e-05	0.000848	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—OPRK1—alcohol dependence	8.37e-05	0.000842	CbGpPWpGaD
Procainamide—SLC22A2—SLC-mediated transmembrane transport—AVP—alcohol dependence	8.33e-05	0.000838	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ADH6—alcohol dependence	8.31e-05	0.000836	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	8.16e-05	0.000821	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	8.13e-05	0.000818	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—MAOA—alcohol dependence	8.04e-05	0.000809	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ADH7—alcohol dependence	7.94e-05	0.000799	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—EP300—alcohol dependence	7.88e-05	0.000793	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—alcohol dependence	7.81e-05	0.000786	CbGpPWpGaD
Procainamide—SLC22A1—SLC-mediated transmembrane transport—AVP—alcohol dependence	7.76e-05	0.000781	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ADH6—alcohol dependence	7.75e-05	0.00078	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ADH1A—alcohol dependence	7.71e-05	0.000776	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—OPRM1—alcohol dependence	7.66e-05	0.000771	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GGT2—alcohol dependence	7.61e-05	0.000766	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—OPRK1—alcohol dependence	7.6e-05	0.000765	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—MAOA—alcohol dependence	7.49e-05	0.000754	CbGpPWpGaD
Procainamide—CYP2D6—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	7.47e-05	0.000751	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CNR1—alcohol dependence	7.46e-05	0.00075	CbGpPWpGaD
Procainamide—CYP2D6—Biological oxidations—CYP2E1—alcohol dependence	7.4e-05	0.000745	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ADH4—alcohol dependence	7.35e-05	0.00074	CbGpPWpGaD
Procainamide—CYP2D6—Metapathway biotransformation—CYP2E1—alcohol dependence	7.3e-05	0.000735	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	7.27e-05	0.000732	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	7.27e-05	0.000732	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—EP300—alcohol dependence	7.21e-05	0.000725	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—NPY—alcohol dependence	7.05e-05	0.000709	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ADH1B—alcohol dependence	6.96e-05	0.0007	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ADH1A—alcohol dependence	6.89e-05	0.000693	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CRH—alcohol dependence	6.8e-05	0.000684	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—HTR1B—alcohol dependence	6.8e-05	0.000684	CbGpPWpGaD
Procainamide—CYP2D6—Biological oxidations—GGT1—alcohol dependence	6.8e-05	0.000684	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—AVP—alcohol dependence	6.75e-05	0.000679	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—AVP—alcohol dependence	6.73e-05	0.000677	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ADH4—alcohol dependence	6.56e-05	0.00066	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ADH1A—alcohol dependence	6.42e-05	0.000646	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	6.36e-05	0.00064	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ADH7—alcohol dependence	6.25e-05	0.000629	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	6.12e-05	0.000616	CbGpPWpGaD
Procainamide—CYP2D6—Biological oxidations—MAOA—alcohol dependence	6.09e-05	0.000613	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GGT2—alcohol dependence	5.99e-05	0.000603	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	5.95e-05	0.000598	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—DRD4—alcohol dependence	5.95e-05	0.000598	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	5.9e-05	0.000593	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ADH4—alcohol dependence	5.86e-05	0.000589	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—EP300—alcohol dependence	5.83e-05	0.000587	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—MAOB—alcohol dependence	5.77e-05	0.00058	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CNR1—alcohol dependence	5.68e-05	0.000571	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	5.68e-05	0.000571	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—OPRD1—alcohol dependence	5.63e-05	0.000566	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—EP300—alcohol dependence	5.58e-05	0.000561	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ADH7—alcohol dependence	5.58e-05	0.000561	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—HTR7—alcohol dependence	5.54e-05	0.000557	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—DRD2—alcohol dependence	5.54e-05	0.000557	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ADH1B—alcohol dependence	5.48e-05	0.000551	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ADH4—alcohol dependence	5.46e-05	0.000549	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PDYN—alcohol dependence	5.39e-05	0.000543	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—EP300—alcohol dependence	5.36e-05	0.000539	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—EP300—alcohol dependence	5.36e-05	0.000539	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GGT2—alcohol dependence	5.35e-05	0.000538	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—EP300—alcohol dependence	5.17e-05	0.00052	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—EP300—alcohol dependence	5.17e-05	0.00052	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	5.12e-05	0.000515	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—POMC—alcohol dependence	5.12e-05	0.000515	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—OPRD1—alcohol dependence	5.11e-05	0.000514	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	5.09e-05	0.000513	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CRHR1—alcohol dependence	5.02e-05	0.000505	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ADH7—alcohol dependence	4.98e-05	0.000501	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ALDH2—alcohol dependence	4.9e-05	0.000494	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PDYN—alcohol dependence	4.9e-05	0.000493	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ADH1B—alcohol dependence	4.89e-05	0.000492	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GGT2—alcohol dependence	4.77e-05	0.00048	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	4.77e-05	0.00048	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—EP300—alcohol dependence	4.71e-05	0.000474	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—AVP—alcohol dependence	4.66e-05	0.000469	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ADH7—alcohol dependence	4.64e-05	0.000467	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CRHR1—alcohol dependence	4.55e-05	0.000458	CbGpPWpGaD
Procainamide—ACHE—Metabolism—MAOB—alcohol dependence	4.54e-05	0.000457	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—OPRK1—alcohol dependence	4.49e-05	0.000452	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GGT2—alcohol dependence	4.45e-05	0.000448	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ADH1B—alcohol dependence	4.37e-05	0.000439	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—OPRM1—alcohol dependence	4.33e-05	0.000436	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ADH6—alcohol dependence	4.28e-05	0.000431	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—AVP—alcohol dependence	4.23e-05	0.000426	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GOT2—alcohol dependence	4.17e-05	0.00042	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ADH1B—alcohol dependence	4.07e-05	0.000409	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	4.07e-05	0.000409	CbGpPWpGaD
Procainamide—BCHE—Metabolism—MAOB—alcohol dependence	4.05e-05	0.000408	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—NPY—alcohol dependence	3.98e-05	0.000401	CbGpPWpGaD
Procainamide—CYP2D6—Biological oxidations—POMC—alcohol dependence	3.97e-05	0.000399	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—AVP—alcohol dependence	3.94e-05	0.000397	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—OPRM1—alcohol dependence	3.93e-05	0.000396	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CYP2E1—alcohol dependence	3.92e-05	0.000395	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—HTR2A—alcohol dependence	3.88e-05	0.00039	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ALDH2—alcohol dependence	3.86e-05	0.000388	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CRH—alcohol dependence	3.84e-05	0.000387	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—HTR1B—alcohol dependence	3.84e-05	0.000387	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	3.71e-05	0.000374	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—EP300—alcohol dependence	3.63e-05	0.000365	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—NPY—alcohol dependence	3.62e-05	0.000364	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—MAOB—alcohol dependence	3.62e-05	0.000364	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GOT1—alcohol dependence	3.6e-05	0.000362	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GGT1—alcohol dependence	3.6e-05	0.000362	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ADH1A—alcohol dependence	3.55e-05	0.000357	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HTR1B—alcohol dependence	3.49e-05	0.000351	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CRH—alcohol dependence	3.49e-05	0.000351	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ALDH2—alcohol dependence	3.44e-05	0.000347	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—MAOB—alcohol dependence	3.37e-05	0.000339	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—DRD4—alcohol dependence	3.36e-05	0.000338	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	3.31e-05	0.000333	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GOT2—alcohol dependence	3.28e-05	0.00033	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—MAOA—alcohol dependence	3.23e-05	0.000325	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CNR1—alcohol dependence	3.21e-05	0.000323	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—POMC—alcohol dependence	3.21e-05	0.000323	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—HTR7—alcohol dependence	3.13e-05	0.000315	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—DRD2—alcohol dependence	3.13e-05	0.000315	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—POMC—alcohol dependence	3.1e-05	0.000312	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CYP2E1—alcohol dependence	3.09e-05	0.000311	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ALDH2—alcohol dependence	3.08e-05	0.00031	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—DRD4—alcohol dependence	3.05e-05	0.000307	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—OPRD1—alcohol dependence	3.02e-05	0.000304	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ADH4—alcohol dependence	3.01e-05	0.000303	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GOT2—alcohol dependence	2.93e-05	0.000295	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CNR1—alcohol dependence	2.91e-05	0.000293	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PDYN—alcohol dependence	2.89e-05	0.000291	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ALDH2—alcohol dependence	2.87e-05	0.000289	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—POMC—alcohol dependence	2.86e-05	0.000288	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HTR7—alcohol dependence	2.84e-05	0.000286	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—DRD2—alcohol dependence	2.84e-05	0.000286	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GGT1—alcohol dependence	2.83e-05	0.000285	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GOT1—alcohol dependence	2.83e-05	0.000285	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CYP2E1—alcohol dependence	2.75e-05	0.000277	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CRHR1—alcohol dependence	2.69e-05	0.000271	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—WASF2—alcohol dependence	2.69e-05	0.000271	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—AVP—alcohol dependence	2.63e-05	0.000265	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GOT2—alcohol dependence	2.62e-05	0.000263	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—WASF1—alcohol dependence	2.58e-05	0.00026	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ADH7—alcohol dependence	2.56e-05	0.000258	CbGpPWpGaD
Procainamide—ACHE—Metabolism—MAOA—alcohol dependence	2.54e-05	0.000256	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GOT1—alcohol dependence	2.53e-05	0.000254	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GGT1—alcohol dependence	2.53e-05	0.000254	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.46e-05	0.000248	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CYP2E1—alcohol dependence	2.46e-05	0.000247	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GGT2—alcohol dependence	2.46e-05	0.000247	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GOT2—alcohol dependence	2.44e-05	0.000245	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AVP—alcohol dependence	2.39e-05	0.000241	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—OPRM1—alcohol dependence	2.32e-05	0.000234	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYP2E1—alcohol dependence	2.29e-05	0.000231	CbGpPWpGaD
Procainamide—BCHE—Metabolism—MAOA—alcohol dependence	2.27e-05	0.000228	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GGT1—alcohol dependence	2.26e-05	0.000227	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GOT1—alcohol dependence	2.26e-05	0.000227	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ADH1B—alcohol dependence	2.25e-05	0.000226	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.2e-05	0.000221	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—HTR2A—alcohol dependence	2.19e-05	0.000221	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NPY—alcohol dependence	2.14e-05	0.000215	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GGT1—alcohol dependence	2.1e-05	0.000212	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GOT1—alcohol dependence	2.1e-05	0.000212	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—POMC—alcohol dependence	2.1e-05	0.000211	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CRH—alcohol dependence	2.06e-05	0.000207	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HTR1B—alcohol dependence	2.06e-05	0.000207	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—MAOA—alcohol dependence	2.02e-05	0.000204	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HTR2A—alcohol dependence	1.99e-05	0.0002	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—MAOA—alcohol dependence	1.89e-05	0.00019	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—MAOB—alcohol dependence	1.86e-05	0.000187	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—DRD4—alcohol dependence	1.8e-05	0.000181	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—POMC—alcohol dependence	1.75e-05	0.000176	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CNR1—alcohol dependence	1.72e-05	0.000173	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HTR7—alcohol dependence	1.68e-05	0.000169	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—DRD2—alcohol dependence	1.68e-05	0.000169	CbGpPWpGaD
Procainamide—ACHE—Metabolism—POMC—alcohol dependence	1.65e-05	0.000166	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—POMC—alcohol dependence	1.59e-05	0.00016	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ALDH2—alcohol dependence	1.58e-05	0.000159	CbGpPWpGaD
Procainamide—BCHE—Metabolism—POMC—alcohol dependence	1.48e-05	0.000148	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AVP—alcohol dependence	1.41e-05	0.000142	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—EP300—alcohol dependence	1.39e-05	0.00014	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GOT2—alcohol dependence	1.35e-05	0.000135	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—POMC—alcohol dependence	1.32e-05	0.000133	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP2E1—alcohol dependence	1.27e-05	0.000127	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—POMC—alcohol dependence	1.23e-05	0.000124	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HTR2A—alcohol dependence	1.18e-05	0.000118	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GOT1—alcohol dependence	1.16e-05	0.000117	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GGT1—alcohol dependence	1.16e-05	0.000117	CbGpPWpGaD
Procainamide—ACHE—Metabolism—EP300—alcohol dependence	1.1e-05	0.00011	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—MAOA—alcohol dependence	1.04e-05	0.000105	CbGpPWpGaD
Procainamide—BCHE—Metabolism—EP300—alcohol dependence	9.78e-06	9.85e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—POMC—alcohol dependence	9.39e-06	9.45e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—EP300—alcohol dependence	8.74e-06	8.79e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—EP300—alcohol dependence	8.15e-06	8.2e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—POMC—alcohol dependence	6.78e-06	6.82e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—EP300—alcohol dependence	6.23e-06	6.27e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—EP300—alcohol dependence	4.5e-06	4.53e-05	CbGpPWpGaD
